A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Booster vaccination with messenger RNA (mRNA) vaccines has been offered to adults in
England starting on 14 September 2021. We used a test-negative case–control design to …
England starting on 14 September 2021. We used a test-negative case–control design to …
Duration of protection against mild and severe disease by Covid-19 vaccines
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Antibody responses are an important part of immunity after Coronavirus Disease 2019
(COVID-19) vaccination. However, antibody trajectories and the associated duration of …
(COVID-19) vaccination. However, antibody trajectories and the associated duration of …
Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant …
CJ Callaghan, L Mumford, RMK Curtis… - …, 2022 - journals.lww.com
Background. The clinical effectiveness of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet …
syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet …
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine …
MML Kho, AL Messchendorp, SC Frölke… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
Effectiveness of BNT162b2 against COVID-19 in adolescents
AA Powell, F Kirsebom, J Stowe, K McOwat… - The Lancet Infectious …, 2022 - thelancet.com
In the UK, COVID-19 vaccination for adults began in December, 2020. 1 Because children
and adolescents have a low risk of severe COVID-19 and due to concerns about rare but …
and adolescents have a low risk of severe COVID-19 and due to concerns about rare but …
Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies …
DM Skowronski, Y Febriani, M Ouakki… - Clinical Infectious …, 2022 - academic.oup.com
Abstract Background The Canadian coronavirus disease 2019 (COVID-19) immunization
strategy deferred second doses and allowed mixed schedules. We compared 2-dose …
strategy deferred second doses and allowed mixed schedules. We compared 2-dose …
Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study
M Shrotri, E Fragaszy, V Nguyen… - Nature …, 2022 - nature.com
Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …
however, vaccine-derived immunity may not protect all groups equally, and the durability of …